Onspira Therapeutics has a total of 17 patents globally, out of which 8 have been granted. Of these 17 patents, more than 94% patents are active. The USA is where Onspira Therapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the USA seems to be the main focused R&D center of Onspira Therapeutics and is also the origin country of the firm.
Onspira Therapeutics was founded in the year 2017. The company operates as a clinical-stage biopharmaceutical firm.
Do read about some of the most popular patents of Onspira Therapeutics which have been covered by us in this article and also you can find Onspira Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Onspira Therapeutics patent portfolio.
How many patents does Onspira Therapeutics have?
Onspira Therapeutics has a total of 17 patents globally. These patents belong to 6 unique patent families. Out of 17 patents, 16 patents are active.
How Many Patents did Onspira Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Onspira Therapeutics Applications Filed | Onspira Therapeutics Patents Granted |
2022 | 1 | – |
2021 | 4 | 2 |
2020 | 2 | 1 |
2019 | 2 | 1 |
2018 | – | – |
2017 | 1 | – |
2016 | – | 1 |
2015 | 1 | 1 |
2014 | 1 | 1 |
2013 | 1 | – |
How many Onspira Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Onspira Therapeutics File in Different Countries?
Countries in which Onspira Therapeutics Filed Patents
Country | Patents |
United States Of America | 9 |
Australia | 5 |
Canada | 2 |
Europe | 1 |
Where are Research Centres of Onspira Therapeutics Patents Located?
The R&D Centres of patents filed by Onspira Therapeutics is in the US.
Most Cited Onspira Therapeutics Patent
US8637469B2 is the most popular patent in the Onspira Therapeutics portfolio. It has received 13 citations so far from companies like Therapeutica Borealis.
List of Onspira Therapeutics Patents
Onspira Therapeutics Patents | Title |
US11718853B2 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
US11091763B2 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
US10550389B2 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
US8940683B2 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
US8637469B2 | Rhinosinusitis Prevention And Therapy With Proinflammatory Cytokine Inhibitors |
US20230210768A1 | An Inhaled Il-1 Blockade Treatment For Respiratory Tract Immunopathology |
US20220409627A1 | Treatment Of Lower Airways Disorders |
US20220339099A1 | Compositions Of Interleukin-1 Receptor Antagonist |
EP4153213A1 | An Inhaled Il-1 Blockade Treatment For Respiratory Tract Immunopathology |
AU2019203630B2 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
AU2017200228B2 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
AU2013270447B2 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
AU2021277585A1 | An Inhaled Il-1 Blockade Treatment For Respiratory Tract Immunopathology |
AU2020395766A1 | Treatment Of Lower Airways Disorders |
CA2660519A1 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
CA3177366A1 | Localized Therapy Of Lower Airways Inflammatory Disorders With Proinflammatory Cytokine Inhibitors |
US20140311482A1 | Rhinosinusitis Prevention And Therapy With Proinflammatory Cytokine Inhibitors |
What are Onspira Therapeutics’ key innovation segments?
What Technologies are Covered by Onspira Therapeutics?
The chart below distributes patents filed by Onspira Therapeutics